Sino Biopharmaceutical Ltd Financials

Market Capitalization HK$52.73 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	22.31
Forward PE	16.11
Price to Sales TTM	HK$1.90
Price to Book MRQ	HK$1.61
Enterprise to Revenue	2.11
Enterprise to EBITDA	8.77

Financial Reports as of Jun. 30, 2021

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2021-06-30
Profit Margin	14.72%
Operating Margin	21.86%
Return on Assets TTM	5.55%
Return on Equity TTM	12.87%

Income Statement

Revenue TTM	HK$29,825,544,781
Revenue per Share TTM	HK$1.51
Quarterly Revenue Growth	11.10%
Gross Profit TTM	HK$24,207,233,566
EBITDA	HK$13,205,607,000
Net Income to Common TTM	HK$2,298,977,778
Diluted EPS TTM	HK$0.13
Quarterly Earnings Growth YoY	139.70%

Balance Sheet

Total Cash MRQ	HK$14,144,509,980
Total Cash per Share MRQ	HK$0.72
Total Debt MRQ	HK$
Total Debt to Equity MRQ	22.97
Current Ratio MRQ	1.15
Book Value per Share MRQ	HK$1.80

Cash Flow

Operating Cash Flow TTM	HK$6,947,209,143
Levered Free Cash Flow TTM	HK$-382,833,457

1177 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	18,183,999,488
Float Shares	9,158,989,493
Avg 10 Volume	69,592,511
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	48.14%
% Held by Institutions	17.47%

Stock Price Summary

Beta	0.69
Fifty Two Week Low	HK$2.29
Fifty Two Week High	HK$4.25
Fifty Two Week Change	-2.44%
Day 50 MA	HK$3.19
Day 200 MA	HK$3.10

Dividends and Splits

Forward Annual Dividend Rate	HK$0.06
Forward Annual Dividend Yield	2.09%
Trailing Annual Dividend Rate	HK$0.06
Trailing Annual Dividend Yield	2.09%
Payout Ratio	39.49%
Dividend Date
Ex Dividend Date	2024-09-10
Last Split Factor
Last Split Date	2020-07-20